Gore ME - Search Results

1

Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma.

Fearfield LA, Larkin JM, Rowe A, A'Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore ME, Bunker CB. Fearfield LA, et al. Among authors: gore me. Br J Dermatol. 2007 Mar;156(3):440-7. doi: 10.1111/j.1365-2133.2006.07581.x. Br J Dermatol. 2007. PMID: 17300231

2

Clinico-pathological features of relapsing very thin melanoma.

Fearfield LA, Rowe A, Francis N, Fisher C, Gore ME, Bunker CB. Fearfield LA, et al. Among authors: gore me. Clin Exp Dermatol. 2001 Nov;26(8):686-95. doi: 10.1046/j.1365-2230.2001.00920.x. Clin Exp Dermatol. 2001. PMID: 11722458 Review.

3

The role of human endogenous retroviruses in melanoma.

Singh S, Kaye S, Gore ME, McClure MO, Bunker CB. Singh S, et al. Among authors: gore me. Br J Dermatol. 2009 Dec;161(6):1225-31. doi: 10.1111/j.1365-2133.2009.09415.x. Epub 2009 Jul 20. Br J Dermatol. 2009. PMID: 19785608 Review.

4

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities.

Sinha R, Edmonds K, Newton-Bishop JA, Gore ME, Larkin J, Fearfield L. Sinha R, et al. Among authors: gore me. Br J Dermatol. 2012 Nov;167(5):987-94. doi: 10.1111/bjd.12010. Br J Dermatol. 2012. PMID: 22913467 Review.

5

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies.

Gore ME, Larkin JM. Gore ME, et al. Br J Cancer. 2011 Feb 1;104(3):399-406. doi: 10.1038/sj.bjc.6606084. Br J Cancer. 2011. PMID: 21285971 Free PMC article. Review.

6

A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanoma.

Thomas CL, Mortimer PS, Larkin JM, Basu TN, Gore ME, Fearfield L. Thomas CL, et al. Among authors: gore me. Clin Exp Dermatol. 2016 Apr;41(3):267-71. doi: 10.1111/ced.12722. Epub 2015 Sep 28. Clin Exp Dermatol. 2016. PMID: 26411345

7

Malignant melanoma (metastatic).

Larkin J, Gore M. Larkin J, et al. BMJ Clin Evid. 2008 Aug 22;2008:1718. BMJ Clin Evid. 2008. PMID: 19445806 Free PMC article. Review.

8

Revisiting the past: utilizing archival tissue for the detection and quantification of gene expression.

Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure MO, Bunker CB. Singh S, et al. Among authors: gore me. Br J Dermatol. 2009 Apr;160(4):885-6. doi: 10.1111/j.1365-2133.2009.09039.x. Epub 2009 Feb 16. Br J Dermatol. 2009. PMID: 19222465 No abstract available.

9

Revised U.K. guidelines for the management of cutaneous melanoma 2010.

Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, Gore ME, Lorigan P, MacKie R, Nathan P, Peach H, Powell B, Walker C; British Association of Dermatologists Clinical Standards Unit. Marsden JR, et al. Among authors: gore me. Br J Dermatol. 2010 Aug;163(2):238-56. doi: 10.1111/j.1365-2133.2010.09883.x. Epub 2010 Jul 1. Br J Dermatol. 2010. PMID: 20608932 No abstract available.

10

Second primary melanomas on treatment with vemurafenib: reply from the authors.

Fearfield L, Newton-Bishop JA, Sinha R, Edmonds K, Gore ME, Larkin J. Fearfield L, et al. Among authors: gore me. Br J Dermatol. 2013 Apr;168(4):888-9. doi: 10.1111/bjd.12094. Br J Dermatol. 2013. PMID: 23066884 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters